Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Spinal Cerebral Ataxia (SCA) Type-17 is typically within 14-21 days from the date of sample collection.

What are the prerequisites for the test Spinal Cerebral Ataxia (SCA) Type- 17

  • Genetic counseling
  • Fasting before the test
  • Previous diagnosis of SCA or family history of the condition
  • Consultation with a neurologist
  • Consent form signed by the patient or legal guardian

What are the measure values for the test Spinal Cerebral Ataxia (SCA) Type- 17

  • Measure 1: Gait ataxia - assessed using the Scale for the Assessment and Rating of Ataxia (SARA) with a score ranging from 0 (no ataxia) to 40 (severe ataxia)
  • Measure 2: Dysarthria - assessed using the Dysarthria Severity Scale with a score ranging from 0 (no dysarthria) to 4 (severe dysarthria)
  • Measure 3: Finger chase test - assessed by the time taken to complete a finger chase test with a score ranging from 0 (normal performance) to 5 (severely impaired performance)
  • Measure 4: Brain MRI - assessed for cerebellar atrophy and other structural abnormalities

What does this test Spinal Cerebral Ataxia (SCA) Type- 17 identify?

  1. Spinal Cerebellar Ataxia (SCA) Type-17 is a genetic test that identifies mutations in the TBP gene.
  2. It is used to diagnose individuals with SCA Type-17, which is a rare form of inherited ataxia that affects coordination and balance.
  3. Individuals with mutations in the TBP gene may experience symptoms such as unsteadiness, slurred speech, and difficulty with fine motor skills.
  4. Early detection of SCA Type-17 through genetic testing can help in providing appropriate medical management and support for affected individuals and their families.

Why is this test Spinal Cerebral Ataxia (SCA) Type- 17 taken?

Spinal Cerebral Ataxia (SCA) Type- 17 Test

This test is taken to diagnose Spinal Cerebral Ataxia (SCA) Type-17, which is a genetic disorder that affects the nervous system. SCA Type-17 is characterized by progressive problems with coordination and balance, as well as other neurological symptoms.

Early diagnosis of SCA Type-17 is important for proper management and treatment of the condition. This test helps in identifying the specific genetic mutation associated with SCA Type-17, which can aid in making informed decisions about treatment and care.

Individuals with a family history of SCA Type-17 or who are experiencing symptoms such as unsteadiness, difficulty walking, and slurred speech may be recommended to undergo this test to confirm the diagnosis and start appropriate interventions.

No FAQs available.

Customer Google Rating